Mary L Disis

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Yingdong Zhao, Holden Maecker, Sylvia Janetzki, 2008, Journal of Translational Medicine.

Conflicts of interest in translational research

Malcolm R. Parks, M. Disis, Mary L Disis, 2004, Journal of Translational Medicine.

Defining the critical hurdles in cancer immunotherapy

Zhigang Tian, Sylvia Janetzki, Cedrik M Britten, 2011, Journal of Translational Medicine.

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

Holden T Maecker, V. Maino, H. Maecker, 2008, BMC Immunology.

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors

Holden T Maecker, V. Maino, H. Maecker, 2007, Journal of immune based therapies and vaccines.

Maximizing the Retention of Antigen Specific Lymphocyte Function after Cryopreservation

Holden T Maecker, V. Maino, H. Maecker, 2001 .